The Q1 2025 financial report of DNA Company shows revenue of $10 million, a 15% increase compared to the same period last year. Net profit reached $2 million, improving by 20% due to reduced operating costs. Total assets grew by 5% to $50 million, with $15 million in cash, ensuring liquidity. The company has expanded its market to Europe, contributing to revenue growth. Research and Development (R&D) expenses accounted for 10% of revenue, highlighting DNA’s commitment to technological innovation. For Q2 2025, DNA is expected to continue achieving growth through upcoming new products and an expanded market.
Leave a Reply